“I am very impressed with the thoroughness of the analysis. I hope to steer more data your way soon. Again, thank you for undertaking this at a small cost. It is much appreciated.”
“Thanks for getting this back so quickly, and for the thoroughness of the design and report. We look forward to working with you again!”
“A pleasure to work with. Concise and detailed report for our 3D cell assay. We’ll have more projects your way soon!”
“Extremely impressive work, thanks for getting this back to us so quickly. I really appreciate the detailed analysis.”
Spotlight
NASH 3D Cell Culture Assays
Our expertise in 3D cell culture models and quantitative evaluation allows for an unparalleled evaluation of compounds which ameliorate the NASH continuum.
Biomarker Co-localization and Quantification
We perform quantitative analysis of distribution, colocalization and spatial relationships of biomarkers and cells detected in H&E, IF, multiplex IHC and ISH slides.
Tissue Analysis for Immuno-oncology
Automated analysis of the number, distribution, and infiltration of immune cell sub-types within tumor tissue specimens.
Featured Posts
Using Noise Reduction Methods in ImageJ to Produce High Quality Data
After completing the imaging process for your desired biological model, you may find that some of your images have artifacts that are likely not a part of the true signal you’re attempting to extract. [...]
Leica Biosystems and Visikol to Host Multiplex Webinar
Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica VERSA 8. Through this presentation, Visikol will provide a background on various multiplex tissue imaging [...]
Our Multiplex Immunolabeling Approach
Immunohistochemistry is routinely used to localize and study the distribution of proteins in tissues. Most staining methods are limited to localizing one or two proteins in samples. With the recent advances in the field [...]
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, and histopathology services. Visikol is focused on transforming tissues into actionable insights that allow researchers [...]
Using Immuno- histochemistry and Multiplex Slide Labeling for Tumor Research
Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues in cancer treatment. To address these issues, clinical samples derived from patients are typically analyzed [...]
Visikol Expands Hampton Facility to Accommodate Service Growth
2020 was a challenging year for all industries and the life sciences field was no exception. Throughout 2020, Visikol continued to maintain its commitments to its clients and their life-saving and life-extending drug discovery [...]
